Intravenous immunoglobulins improve live birth rate among women with underlying immune conditions and recurrent pregnancy loss: a systematic review and meta-analysis

Intravenous immunoglobulin (IVIG) is increasingly used as a treatment for recurrent pregnancy loss (RPL) despite lack of clear evidence on efficacy. Recent data suggest IVIG might be more effective in a subgroup of women with an aberrant immunological profile. Therefore, a systematic review and meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Habets, Denise H. J., Pelzner, Kim, Wieten, Lotte, Spaanderman, Marc E. A., Villamor, Eduardo, Al-Nasiry, Salwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917719/
https://www.ncbi.nlm.nih.gov/pubmed/35277202
http://dx.doi.org/10.1186/s13223-022-00660-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917719/
https://www.ncbi.nlm.nih.gov/pubmed/35277202
http://dx.doi.org/10.1186/s13223-022-00660-8

Ejemplares similares